171 related articles for article (PubMed ID: 34666791)
1. Long-term remission of AIDS-related primary central nervous system lymphoma in a patient under antiretroviral therapy: a case report and review of the literature.
Gijs PJ; Clerc O
AIDS Res Ther; 2021 Oct; 18(1):76. PubMed ID: 34666791
[TBL] [Abstract][Full Text] [Related]
2. Highly active antiretroviral therapy as the sole treatment for AIDS-related primary central nervous system lymphoma: a case report with implications for treatment.
Aboulafia DM; Puswella AL
AIDS Patient Care STDS; 2007 Dec; 21(12):900-7. PubMed ID: 18154487
[TBL] [Abstract][Full Text] [Related]
3. Highly Active Antiretroviral Therapy and Gamma Knife Radiosurgery for the Treatment of AIDS-Related Primary Central Nervous System Lymphoma.
Alvarez-Pinzon AM; Valerio JE; Swedberg HN; Elwasila SM; Wolf A; Alonso JR
World Neurosurg; 2019 Apr; 124():310-312. PubMed ID: 30654158
[TBL] [Abstract][Full Text] [Related]
4. The management of primary central nervous system lymphoma related to AIDS in the HAART era.
González-Aguilar A; Soto-Hernández JL
Curr Opin Oncol; 2011 Nov; 23(6):648-53. PubMed ID: 21946245
[TBL] [Abstract][Full Text] [Related]
5. Survival is prolonged by highly active antiretroviral therapy in AIDS patients with primary central nervous system lymphoma.
Skiest DJ; Crosby C
AIDS; 2003 Aug; 17(12):1787-93. PubMed ID: 12891064
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival in AIDS-related primary central nervous system lymphoma.
Gupta NK; Nolan A; Omuro A; Reid EG; Wang CC; Mannis G; Jaglal M; Chavez JC; Rubinstein PG; Griffin A; Abrams DI; Hwang J; Kaplan LD; Luce JA; Volberding P; Treseler PA; Rubenstein JL
Neuro Oncol; 2017 Jan; 19(1):99-108. PubMed ID: 27576871
[TBL] [Abstract][Full Text] [Related]
7. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
[TBL] [Abstract][Full Text] [Related]
8. Treatment of HIV-related primary central nervous system lymphoma with AZT high dose, HAART, interleukin-2 and foscarnet in three patients.
Marretta L; Stocker H; Drauz D; Mueller M; Masuhr A; Dieckmann S; Wong V; Koch A; Grueneisen A; Arastéh K; Weiss R
Eur J Med Res; 2011 May; 16(5):197-205. PubMed ID: 21719392
[TBL] [Abstract][Full Text] [Related]
9. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.
Matinella A; Lanzafame M; Bonometti MA; Gajofatto A; Concia E; Vento S; Monaco S; Ferrari S
J Neurol; 2015 May; 262(5):1317-27. PubMed ID: 25877836
[TBL] [Abstract][Full Text] [Related]
10. Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era.
Cingolani A; Fratino L; Scoppettuolo G; Antinori A
J Neurovirol; 2005; 11 Suppl 3():38-44. PubMed ID: 16540454
[TBL] [Abstract][Full Text] [Related]
11. Antiviral and immunomodulatory treatment for AIDS-related primary central nervous system lymphoma: AIDS Malignancies Consortium pilot study 019.
Aboulafia DM; Ratner L; Miles SA; Harrington WJ;
Clin Lymphoma Myeloma; 2006 Mar; 6(5):399-402. PubMed ID: 16640817
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
[TBL] [Abstract][Full Text] [Related]
13. Whole brain radiation alone produces favourable outcomes for AIDS-related primary central nervous system lymphoma in the HAART era.
Nagai H; Odawara T; Ajisawa A; Tanuma J; Hagiwara S; Watanabe T; Uehira T; Uchiumi H; Yotsumoto M; Miyakawa T; Watanabe A; Kambe T; Konishi M; Saito S; Takahama S; Tateyama M; Okada S
Eur J Haematol; 2010 Jun; 84(6):499-505. PubMed ID: 20132301
[TBL] [Abstract][Full Text] [Related]
14. Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery.
Hoffmann C; Tabrizian S; Wolf E; Eggers C; Stoehr A; Plettenberg A; Buhk T; Stellbrink HJ; Horst HA; Jäger H; Rosenkranz T
AIDS; 2001 Nov; 15(16):2119-27. PubMed ID: 11684931
[TBL] [Abstract][Full Text] [Related]
15. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
16. High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease.
Gabarre J; Marcelin AG; Azar N; Choquet S; Lévy V; Lévy Y; Tubiana R; Charlotte F; Norol F; Calvez V; Spina M; Vernant JP; Autran B; Leblond V
Haematologica; 2004 Sep; 89(9):1100-8. PubMed ID: 15377471
[TBL] [Abstract][Full Text] [Related]
17. The role of whole-brain radiotherapy (WBRT) in primary central nervous system lymphoma: is it an alternative to ASCT for consolidation following HD-methotrexate based induction in low-income settings?
de Pádua Covas Lage LA; Araújo Soares V; Meneguin TD; Culler HF; Reichert CO; Jacomassi MD; Reis DGC; Zerbini MCN; de Oliveira Costa R; Rocha V; Pereira J
Radiat Oncol; 2022 Oct; 17(1):171. PubMed ID: 36273167
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients.
Newell ME; Hoy JF; Cooper SG; DeGraaff B; Grulich AE; Bryant M; Millar JL; Brew BJ; Quinn DI
Cancer; 2004 Jun; 100(12):2627-36. PubMed ID: 15197806
[TBL] [Abstract][Full Text] [Related]
19. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
[TBL] [Abstract][Full Text] [Related]
20. Long-term AIDS-related PCNSL outcomes with HD-MTX and combined antiretroviral therapy.
Moulignier A; Lamirel C; Picard H; Lebrette MG; Amiel C; Hamidi M; Polivka M; Mikol J; Cochereau I; Pialoux G
Neurology; 2017 Aug; 89(8):796-804. PubMed ID: 28747447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]